课题基金 / 基金详情

T1 RELAXATION STUDIES TOWARD ISOFORM SELECTIVE INHIBITORS OF NOS

T1 RELAXATION STUDIES TOWARD ISOFORM SELECTIVE INHIBITORS OF NOS
NOS 异构体选择性抑制剂的 T1 弛豫研究
批准号:
6280276
负责人:
WESLEY STRAUB
金额:
$0.01万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-07-01 至 1999-06-30

项目摘要

项目成果

WESLEY STRAUB的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Nitric oxide synthase (NOS) converts arginine to citrulline and the radical diatomic, nitric oxide. Nitric oxide is now well established as a critical messenger molecule in the neural, endothelial and immune systems for both homeostasis and function. High levels of nitric oxide, however, have been also proven to be responsible for toxic shock, cardiac disease and sever brain damage. Inhibition of this enzyme has therefore become of primary importance. Nitric oxide is synthesized in various tissues by select isoforms and ubiquitous nature of nitric oxide production has severe consequences for NOS inhibition since unreasonable side-effects have already been shown to exist during nonselective inhibition. Although the isoforms are highly homologous, we have shown that critical differences between the enzymes do exist and that the active sites of the enzymes are different. I have recently established the NMR parameters for observing the paramagnetic relaxation effects of NOS with arginine and several inhibitors. Th paramagnetic effect of the Fe will be used to obtain distant constraints from the Fe to the proton of each inhibitor and therefore establish overall distance as well as conformational restraints within the active site. Our current work is directed toward obtaining data for all three isoforms with selected inhibitors. Computer Graphics Laboratory resources, including MidasPlus, is used to construct a model of each active site together with relative inhibitor affinities, toward the rational design of isofrom selective inhibitors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DESIGNING ISOFORM SELECTIVE INHIBITORS OF NOS
DESIGNING ISOFORM SELECTIVE INHIBITORS OF NOS
T1 RELAXATION STUDIES TOWARD ISOFORM SELECTIVE INHIBITORS OF NOS
DESIGNING ISOFORM SELECTIVE INHIBITORS OF NOS
海外基金